A new generation of topical chronic wound treatments containing specific MMP inhibitors

Ravi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provid...

Full description

Bibliographic Details
Main Authors: Shrivastava R, Cucuat N, Rousse M, Weig, T, Neto P, Janicot C, Shrivastava C
Format: Article
Language:English
Published: Dove Medical Press 2014-09-01
Series:Chronic Wound Care Management and Research
Subjects:
Online Access:https://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMR
id doaj-05462ba4264a4bffbf65d03e2c92ac9f
record_format Article
spelling doaj-05462ba4264a4bffbf65d03e2c92ac9f2020-11-24T23:36:39ZengDove Medical PressChronic Wound Care Management and Research2324-481X2014-09-012014Issue 1314018209A new generation of topical chronic wound treatments containing specific MMP inhibitorsShrivastava RCucuat NRousse MWeigTNeto PJanicot CShrivastava CRavi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provide symptomatic relief or to assist cicatrization to some extent, but not to directly stimulate cellular growth. Physiologically, chronic wound healing simply requires cell growth to fill the injured cavity. To grow, our cells need to attach onto a cushion, called extracellular matrix (ECM), secreted by the mother cells and composed of multiple proteins. Recent scientific works prove that the concentration of certain matrix metalloproteinases (MMPs) is extremely high in all chronic wounds and, because of their proteolytic nature, some MMPs completely degrade the ECM, hindering cell attachment and cell growth. The aim of this study was to identify, neutralize, and eliminate these MMPs from the wound surface so as to design an effective treatment for chronic wounds. Methods: Acute and chronic models of human epithelial and fibroblast cells were prepared on a defined ECM cushion in vitro and MMPs were added in the culture medium to identify the MMPs causing ECM disintegration for each cell type. ECM-degrading MMPs were then incubated with selected procyanidin-rich plant extracts (PCDs) and cell growth was reanalyzed. Results: It was observed that: 1) multiple MMPs are involved in cellular matrix destruction; 2) ECM-destroying MMPs are specific with respect to cell type; and 3) specific PCDs may bind and neutralize selected MMPs. Conclusion: Topical application of specific plant PCDs to selectively neutralize ECM-destroying MMPs in acute and chronic wounds represents a novel approach for the treatment of superficial and deep skin wounds. Keywords: extra cellular matrix (ECM), matrix metalloproteinases, procyanidins (PCDs), tannins, ulcershttps://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMRExtra Cellular Matrix (ECM)matrix metalloproteinasesprocyanidins (PCDs)tanninsulcers.
collection DOAJ
language English
format Article
sources DOAJ
author Shrivastava R
Cucuat N
Rousse M
Weig
T
Neto P
Janicot C
Shrivastava C
spellingShingle Shrivastava R
Cucuat N
Rousse M
Weig
T
Neto P
Janicot C
Shrivastava C
A new generation of topical chronic wound treatments containing specific MMP inhibitors
Chronic Wound Care Management and Research
Extra Cellular Matrix (ECM)
matrix metalloproteinases
procyanidins (PCDs)
tannins
ulcers.
author_facet Shrivastava R
Cucuat N
Rousse M
Weig
T
Neto P
Janicot C
Shrivastava C
author_sort Shrivastava R
title A new generation of topical chronic wound treatments containing specific MMP inhibitors
title_short A new generation of topical chronic wound treatments containing specific MMP inhibitors
title_full A new generation of topical chronic wound treatments containing specific MMP inhibitors
title_fullStr A new generation of topical chronic wound treatments containing specific MMP inhibitors
title_full_unstemmed A new generation of topical chronic wound treatments containing specific MMP inhibitors
title_sort new generation of topical chronic wound treatments containing specific mmp inhibitors
publisher Dove Medical Press
series Chronic Wound Care Management and Research
issn 2324-481X
publishDate 2014-09-01
description Ravi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provide symptomatic relief or to assist cicatrization to some extent, but not to directly stimulate cellular growth. Physiologically, chronic wound healing simply requires cell growth to fill the injured cavity. To grow, our cells need to attach onto a cushion, called extracellular matrix (ECM), secreted by the mother cells and composed of multiple proteins. Recent scientific works prove that the concentration of certain matrix metalloproteinases (MMPs) is extremely high in all chronic wounds and, because of their proteolytic nature, some MMPs completely degrade the ECM, hindering cell attachment and cell growth. The aim of this study was to identify, neutralize, and eliminate these MMPs from the wound surface so as to design an effective treatment for chronic wounds. Methods: Acute and chronic models of human epithelial and fibroblast cells were prepared on a defined ECM cushion in vitro and MMPs were added in the culture medium to identify the MMPs causing ECM disintegration for each cell type. ECM-degrading MMPs were then incubated with selected procyanidin-rich plant extracts (PCDs) and cell growth was reanalyzed. Results: It was observed that: 1) multiple MMPs are involved in cellular matrix destruction; 2) ECM-destroying MMPs are specific with respect to cell type; and 3) specific PCDs may bind and neutralize selected MMPs. Conclusion: Topical application of specific plant PCDs to selectively neutralize ECM-destroying MMPs in acute and chronic wounds represents a novel approach for the treatment of superficial and deep skin wounds. Keywords: extra cellular matrix (ECM), matrix metalloproteinases, procyanidins (PCDs), tannins, ulcers
topic Extra Cellular Matrix (ECM)
matrix metalloproteinases
procyanidins (PCDs)
tannins
ulcers.
url https://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMR
work_keys_str_mv AT shrivastavar anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT cucuatn anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT roussem anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT weig anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT t anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT netop anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT janicotc anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT shrivastavac anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT shrivastavar newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT cucuatn newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT roussem newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT weig newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT t newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT netop newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT janicotc newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
AT shrivastavac newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors
_version_ 1725522077971120128